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Summary: Our objective was to compare the platelet count and platelet indices of smoking and non-smoking
women at different stages of normal pregnancy.
Study design: In 247 non-smoking and 123 smoking healthy pregnant women the platelet count, the mean platelet
volume, the platelet distribution width and the plateletcrit were compared at 0—10, 11—20, 21—30 and 31—40
weeks of pregnancy. Exclusion criteria were a diastolic pressure ^ 90 mmHg, an endocrine disease, a coagulation
disorder, acetylsalicylic acid or phenprocoumon use. A women was considered a smoker if she smoked more than
4 cigarettes a day. Non-smokers were defined as women reporting no smoking at all. Blood samples were run on
the Sysmex NE-8000.
Results: There was no significant difference between the platelet count in the two groups. In the non-smoking
group, the platelet count showed a significant decrease with gestational age (287 X 109/1 to 258 X 109/1). This was
not the case in the smokers group. The mean platelet volume of the smokers was significantly lower than that of
the non-smokers in the last ten weeks of pregnancy (10.4 fl versus 10.7 fl). The platelet distribution width and the
plateletcrit did not change under the influence of cigarette smoking.
Conclusion: Smoking during pregnancy does not significantly affect platelet count or platelet indices.
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stages (0-10, 11-20, 21-30, 31-40 weeks) of pregnancy. Not
all patients were checked in all four stages.
Exclusion criteria were a diastolic pressure ^ 90 mmHg, an en-
docrine disease or a coagulation disorder. None of the patients used
acetylsalicylic acid or phenprocoumon. The known duration of the
gestation was based on the last menstrual period and an ultrasound
determination between 8 and 14 weeks. The number of cigarettes
smoked per day was estimated by the patient, in most cases con-
firmed by her partner. A women was considered a smoker if she
smoked more than 4 cigarettes a day. The group of women who
smoked more than 15 cigarettes a day was too small to subdivide
the smokers into an intermediate smoking level group (5-15 ciga-
rettes per day) and a group of heavy smokers (> 15 cigarettes per
day). Non-smokers were defined as women reporting no smoking
at all. The basic characteristics of these patients are given in table 1.
Blood samples were drawn between 8.30 and 9.30 a.m. into
EDTA-K2 containing tubes (Sarstedt, Germany) and kept at room
temperature for at most 5 hours before they were run on the Sys-
mex NE-8000 (TOA Medical Electronics Corp., Kobe, Japan) Cor-
relations were determined by linear regression analysis with the
method of the least squares. The significance of the differences of
the median values of the various groups was assessed by the Mann-
Wliitney-Wilcoxon test.
to 264 X 109/1 in the smokers group however was not
significant (p = 0.86).
The MPV of the smokers was significantly lower than
the volume of the non-smokers in the last ten weeks of
pregnancy (10.4 versus 10.7; p = 0.02). The MPV in the
non-smoking group did not charge during gestation.
This quantity was also more or less stable in the smoking
group. The PDW of the two groups is compared and did
not change under the influence of smoking. There was
also no difference in the plateletcrit values. In the non-
smoking group the PDW increased significantly from
the beginning to the end of pregnancy (11.7% to 12.3%;
p = 0.03). This was not the case in the smoking group.
The PCT in the non-smokers decreased significantly
throughout pregnancy (26.3 1/1 to 24.9 l/l; p = 0.04). The
PCT in the smokers also decreased throughout preg-
nancy, but this difference was not significant.
Results
In table 2 the comparison of the platelet counts of the
smoking and non-smoking females at four stages of
pregnancy is given. In the non-smoking group, the plate-
let count showed a slight but significant decrease with
gestational age. The group started with a median platelet
count of 287 X 109/1 and ended with a platelet count of
258 X 109/1 (p = 0.002). The decrease from 283 X 109/1
Discussion
In the present study the only difference in platelet counts
observed was a slight but significant decrease with ges-
tational age in the non-smoking group. Platelet survival
is known to diminish in late pregnancy (11). This is due
to an accelerated state of coagulation and fibrinolysis
which increases towards term (12). Haemodilution in
pregnancy may be another explanation for the decrease
Tab. 1 Basic characteristics of the pregnant women.
Groups of patients
Non-smokers, normal pregnancy (n = 247)
Smokers, normal pregnancy (n = 123)
Age
(a)
median
(interquartile range)
30
(27-33)
29
(25-32)
Parity
47.9% primi
52.1% multi
47.8% primi
52.2% multi
Cigarettes
per day
median
(interquartile range)
0
10
(5-15)
Tab. 2 Comparison of the platelet counts of the smoking (S) and non-smoking (NS) females at four
stages during normal pregnancy.
Gestational age (weeks)
Patient groups
Sample size
Median (109/1)
Lower quartile (109/1)
Upper quartile (109/1)
p-value of MWW-test
Platelets
0-10
NS
93
2871)
232
325
l) vs. ')
S
46
283 ')
215
322
:n.s.
11-20
NS
66
2642)
230
302
2) vs. :
21-30
S
29
2672)
239
299
'): n. s.
NS
119
2643)
226
308
3) vs. "-
S
45
2833)
247
334
;):n.s.
31-40
NS
180
2584)
.211
302
4) vs. 4;
S
68
2644)
232
312
): n. s.
MWW = Mann-Whitney-Wilcoxon-te$\.
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of platelets (13). It is remarkable that this decrease of
platelets does not occur in the smoking group.
Most platelet studies in normal pregnancy have been
confined to platelet counts, but the platelet count alone
is not conclusive. Platelet size indices provide more in-
formation about platelet biology. The MPV is an indica-
tion of the amount of young platelets. Fay et al. (14)
studied platelet count and indices in blood samples from
2066 healthy women with an uncomplicated pregnancy.
The MPV remained stable until 35 weeks gestation and
rose dramatically thereafter. Ahmed et al. (15) studied
the MPV in healthy pregnants. This quantity remained
constant between the first trimester and the end of nor-
mal pregnancy. In patients who became pre-eclamptic, a
persistent increase in MPV was found. Hutt et al. (16)
found that the MPV increased 2—3 weeks before the
development of pre-eclampsia.
In our study the MPV was significantly lower in the last
ten weeks of pregnancy in the smoking than in the non-
smoking group. The MPV of the non-smokers remained
almost constant from the beginning to the end of preg-
nancy.
Less has been published regarding PDW and PCT in
pregnancy. In the present study these indices remained
more or less constant in both smoking and non-smoking
women throughout pregnancy. This is an accordance
with earlier results of our group (17), in which platelet
indices were studied in normal pregnancy.
In several studies the effect of the smoking constituents
nicotine and carbon monoxide on platelet aggregation in
non-pregnants has been evaluated in vivo and in vitro
(18—21). They generally showed evidence of platelet
activation. Smokers had an enhanced aggregation of
platelets, although the platelet count did not differ from
non-smokers. The present study indicates that smoking
during pregnancy does not affect platelet count and
platelet indices in a clinically relevant way.
However, the effect of the combination of smoking and
pregnancy on platelet aggregation still has to be as-
sessed.
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